HomeInsightsPE

Balaxi Pharmaceuticals Ltd PE Ratio

Balaxi Pharmaceuticals Ltd PE Ratio

stocks purchased

₹ 0.7 Cr

Volume transacted

stocks purchased

64.3 K

stocks traded

Last Updated time: 20 Sep 9.00 AM

Image

Balaxi Pharmaceuticals Ltd

NSE: BALAXI

PE

16

Last updated: 20 Sep 9.00 AM

Key Highlights

  • The P/E Ratio of Balaxi Pharmaceuticals Ltd is 16 as of 20 Sep 9.00 AM.
  • The P/E Ratio of Balaxi Pharmaceuticals Ltd changed from 5.9 on March 2019 to 0 on March 2024 . This represents a CAGR of -100.00% over 6 years. .
  • The Latest Trading Price of Balaxi Pharmaceuticals Ltd is ₹ 109.4 as of 19 Sep 15:30.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 21.8. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 164.1. The PE Ratio of Textiles industry is 35.7. In 2024.

Historical P/E Ratio of Balaxi Pharmaceuticals Ltd

No data available

Company Fundamentals for Balaxi Pharmaceuticals Ltd

No data available

Image

Balaxi Pharmaceuticals Ltd

NSE: BALAXI

PRICE

109.4

-2.07 (-1.86%)

stock direction

Last updated: 19 Sep 15:30

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Balaxi Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
19 Sep 2024109.4
18 Sep 2024111.47
17 Sep 2024113.93
16 Sep 2024109.87
13 Sep 2024110.27
12 Sep 2024111.34
11 Sep 2024109.67
10 Sep 2024112.18
09 Sep 2024112.58
06 Sep 2024105.39

SWOT Analysis Of Balaxi Pharmaceuticals Ltd

Strength

4

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Balaxi Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Balaxi Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Balaxi Pharmaceuticals Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Balaxi Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Balaxi Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Balaxi Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Balaxi Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payout of Balaxi Pharmaceuticals Ltd

No data available

* All values are in %

About Balaxi Pharmaceuticals Ltd

  • Balaxi Ventures Limited was formerly incorporated in the name of 'The Anandam Rubber Company Limited' on September 28, 1942.
  • The Company changed its name from 'The Anandam Rubber Company Limited' to 'Balaxi Ventures Limited' on August 08, 2017.
  • The Company incorporated with a basic objective of running rubber and tea plantations and owns several plantations across South India.
  • In year 1989 the company sold its entire plantations to meet the emerging business needs and started concentrating in Investments and trading.
  • The company previously was a investment company, but the company during the financial year 2018-19 has commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG Products On 15 March 2017, Balaxi Overseas Private Limited (BOPL) entered into a Share Purchase Agreement (SPA) with the erstwhile promoters of Company (i.

Balaxi Pharmaceuticals Ltd News Hub

News

Balaxi Pharmaceuticals to conduct AGM

Balaxi Pharmaceuticals announced that the 81st Annual General Meeting(AGM) of the company ...

Read more

01 Aug 202412:52

News

Balaxi Pharmaceuticals to convene board meeting

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2 A...

Read more

26 Jul 202410:45

News

Balaxi Pharma soars after expanding market presence in Angola & Latin America

In a regulatory filing made during market hours today, Balaxi Pharma stated that it has ha...

Read more

25 Jun 202412:14

News

Balaxi Pharmaceuticals to conduct board meeting

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 ...

Read more

24 May 202418:51

News

Balaxi Pharma edges higher after board approves stock split proposal

Accordingly, one equity share of the company, having face value of Rs 10 each, would be su...

Read more

28 Feb 202413:39

News

Balaxi Pharmaceuticals announces board meeting date

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 ...

Read more

10 Feb 202412:43

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Balaxi Pharmaceuticals Ltd

What is the current PE Ratio of Balaxi Pharmaceuticals Ltd?

The Current PE Ratio of Balaxi Pharmaceuticals Ltd is 16.04 as on 20 Sep 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 20 Sep 2024.

What was the PE Ratio of Balaxi Pharmaceuticals Ltd last year?

The PE Ratio of Balaxi Pharmaceuticals Ltd was 11.75 last year, now the PE ratio is 16.04, showing a year-on-year growth of 36.5%.

What does the PE Ratio of Balaxi Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Balaxi Pharmaceuticals Ltd is 16.04. This ratio indicates that investors are willing to pay 16.04 times the earnings per share for each share of Balaxi Pharmaceuticals Ltd.

What is the PE Ratio Growth of Balaxi Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Balaxi Pharmaceuticals Ltd grew by 36.5% whereas, the EPS ratio grew by -88.8.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*